Home › Funds › Euclidean Capital LLC › ORIC

Euclidean Capital LLC position in ORIC

ORIC PHARMACEUTICALS INC · Health Care

Euclidean Capital LLC reported holding 989,410 shares of ORIC (ORIC PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$10.7M, representing 2.44% of its reported portfolio and ranking #4 among its reported holdings. Euclidean Capital LLC has disclosed ORIC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)989.41K sh
Reported value held$10.72M
Portfolio Weight2.44%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Euclidean Capital LLC's ORIC position evolved

Euclidean Capital LLC first disclosed a stake in ORIC in Q3 2023 at 989,410 shares (US$6.0M). The position peaked in Q1 2024 at 989,410 shares, worth US$13.6M. Across 12 filings, Euclidean Capital LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 989,410 shares valued at US$10.7M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 989.41K $5.99M New
Q4 2023 989.41K $9.10M Hold
Q1 2024 989.41K $13.60M Hold
Q2 2024 989.41K $7.00M Hold
Q3 2024 989.41K $10.14M Hold
Q4 2024 989.41K $7.98M Hold
Q1 2025 989.41K $5.52M Hold
Q2 2025 989.41K $10.04M Hold
Q3 2025 989.41K $11.87M Hold
Q4 2025 989.41K $8.09M Hold
Q1 2026 989.41K $12.54M Hold
Q2 2026 989.41K $10.72M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ORIC and 13F data

ORIC (ORIC PHARMACEUTICALS INC) is a Health Care company. 40 other funds we track also report a position in ORIC — the largest reported positions include Nextech Invest Ltd. (US$77.6M), EcoR1 Capital, LLC (US$72.9M), SR ONE CAPITAL MANAGEMENT, LP (US$50.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORIC

All ORIC fund holders →

FAQ

How long has Euclidean Capital LLC held ORIC?

Euclidean Capital LLC has disclosed ORIC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Euclidean Capital LLC's current position in ORIC?

As of Q2 2026, Euclidean Capital LLC holds 989.41K shares of ORIC (ORIC PHARMACEUTICALS INC), valued at $10.72M, representing 2.44% of its reported portfolio and ranking #4.

Has Euclidean Capital LLC been buying or selling ORIC?

In the latest 13F filing (Q2 2026), Euclidean Capital LLC held unchanged its position in ORIC. The position peaked in Q1 2024 at 989.41K shares.

Which other funds hold ORIC?

Other major institutional holders of ORIC include Nextech Invest Ltd., EcoR1 Capital, LLC, SR ONE CAPITAL MANAGEMENT, LP, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.